The recently launched Journal of Transition Medicine is a new open access publication in the De Gruyter medicine portfolio that is published in cooperation with the German Society for Transition Medicine (DGfTM). The editors-in-chief of the journal are Dr. Martina Oldhafer of the University Medical Center Schleswig-Holstein and Professor Lars Pape, MD of the Hannover Medical School and is supported by a prestigious international editorial board.
The Journal of Transition Medicine is the first international interdisciplinary journal which exclusively concentrates on transition medicine. The editorial board’s overarching goal for the journal is to improve the quality of medical care for young people with chronic illnesses during their transition into adulthood. In addition to physicians, experts from several professional disciplines involved in transition care – or dedicated to its improvement – such as sociologists, psychologists, social workers and researchers in the healthcare sector, are involved with the journal.
The journal’s concrete objective is to disseminate research results in the area of transition medicine, including biological and behavioral science, public health and even public policy.
“Transition medicine’s importance for society as a whole is growing, and we are offering a publishing home for this research in our program,” said Daniel Tiemann, Editorial Director Medicine & Life Sciences at De Gruyter. “We are very proud to be able to partner with the DGfTM to create this innovative open access journal.”
The Journal of Transition Medicine will publish four issues per year in English. The journal will contain original research articles, reviews and case reports as well as guidelines and recommendations.